| abstract |
The present invention is an inhibitor of poly (ADP-ribose) polymerase (PARP) and is therefore a vascular disease other than cancer, inflammatory disease, reperfusion injury, ischemic symptoms, stroke, renal failure, cardiovascular disease, cardiovascular disease In formula (I) useful for the treatment of diabetes, neurodegenerative diseases, retroviral infections, retinal injury, skin aging and UV-induced skin injury, and as a chemical or radiosensitizer for cancer treatment Relates to the indicated compounds and pharmaceutically acceptable salts or tautomers thereof. [Chemical 1] |